Abstract
Soft tissue sarcomas have been defined as malignant tumors involving nonepithelial extraskeletal tissues of the body, exclusive of the reticuloendothelial system, glia, and supporting tissues of various parenchymal organs [1]. The soft tissues are represented by voluntary muscles, fat, and fibrous tissue, along with the vessels servicing these tissues [1]. By convention, the soft tissues include the peripheral nervous system because tumors arising from nerves present as soft tissue masses and pose similar problems in differential diagnosis and therapy [1]. Embryologically, the soft tissues are derived principally from mesoderm, with some contribution for ectoderm [1].
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Enzinger FM, Weiss SW: General considerations. In: Soft tissue tumors, 2nd edition. Enzinger FM, Weiss SW (eds). St Louis: CV Mosby, pp 1–18, 1989.
Presant CA, Russell WO, Alexander RW, et al.: Soft tissue and bone sarcoma histopathol-ogy peer review: The frequency of disagreement in diagnosis and the need for second pathology opinions: The Southeastern Cancer Study Group experience. J Clin Oncol 4:1658–1661, 1986.
Coindre JM, Trojani M, Contesso G, et al.: Reproducibility of a histopathologic grading system for adult soft tissue sarcomas. Cancer 58:306–309, 1986.
Miser JS, Triche TJ, Pritchard DJ, Kinsella T: Ewing’s sarcoma and the nonrhabdomyo-sarcoma soft tissue sarcomas of childhood. In: Principles and practice of pediatric oncology. Pizzo PA, Poplack DG (eds). Philadelphia: JB Lippincott, pp 678–688, 1989.
Simon MA, Enneking WF: The management of soft tissue sarcomas of the extremities. J Bone Joint Surg (Am) 58:317–327, 1976.
Weingrad DW, Rosenberg SA: Early lymphatic spread osteogenic and soft tissue sarcomas. Surgery 84:231–240, 1978.
Pizzo PA, Horowitz ME, Poplack DG, Hays DM, Kun LE: Solid tumors of childhood. In: Cancer: Principles and practice of oncology, 3rd edition. DeVita VT, Jr, Hillman S, Rosenberg SA (eds). Philadelphia: JB Lippincott, pp 1612–1670, 1989.
Horowitz ME, Pratt CB, Webber BL, et al.: Therapy of childhood soft-tissue sarcomas other than rhabdomyosarcoma: A review of 62 cases treated at a single institution. J Clin Oncol 4:559–564, 1986.
Chang AE, Rosenberg SA: Clinical evaluation and treatment of soft tissue sarcomas. In: Soft tissue tumors, 2nd edition. Enzinger FM, Weiss SW (eds). St Louis: CV Mosby, pp 19–42, 1988.
Chang AE, Rosenberg SA, Glatstein SA, Antman KH: Sarcomas of soft tissues. In: Cancer: Principles and practice of oncology, 3rd edition. DeVita VT, Jr, Hellman S, Rosenberg SA, (eds). Philadelphia: JB Lippincott, pp 1345–1398, 1989.
Mazeron JJ, Suit HD: Lymph nodes as sites of metastases from sarcomas of soft tissue. Cancer 60:1800, 1987.
Lawrence W, Jr, Hays DM, Heyn R, et al.: Lymphatic metastasis with childhood rhabdomyosarcoma: A report from the Intergroup Rhabdomyosarcoma Study. Cancer 60:910–915, 1987.
Kingston JE, McElwain TJ, Malpas JS: Childhood rhabdomyosarcoma: Experience of the Children’ps Solid Tumor Group. Br J Cancer 48:195–207, 1983.
Bunn PA, Jr, Ridgway EC: Paraneoplastic syndromes in cancer. In: Cancer: Principles and practice of oncology, 3rd edition. De Vita VT, Jr, Hellman S, Rosenberg SA (eds). Philadelphia: JB Lippincott, pp 1896–1940, 1989.
Lawrence W, Jr, Gehan EA, Hays DM, et al.: Prognostic significance of staging factors of the UICC staging system in childhood rhabdomyosarcoma: A report from the Intergroup Rhabdomyosarcoma Study (IRS-II). J Clin Oncol 5:46–54, 1987.
Young JL, Jr, Miller RW: Incidence of malignant tumors in U.S. Children. J Pediatr 86:254, 1975.
Flamant F, Hill C: The improvement in survival associated with combined chemotherapy in childhood rhabdomyosarcoma: A historical comparison of 345 patients in the same center. Cancer 53:2417–2421, 1984.
Voute PA, Vos A, de Kraker J, et al.: Rhabdomyosarcoma: Chemotherapy and limited supplementary treatment program to avoid mutilation. Natl Cancer Inst Monogr 56:121-125, 1981.
Treuner J, Suder J, Gerein V, et al.: Behandlungsergebesse der nichtrabdomyosarcomatösen Weichteilmalegnome im Rahmen der CWI-81-Studie. Klin Pediatr 199:209–217, 1987.
Pratt CB, Hustu HO, Kumar APM, et al.: Treatment of childhood rhabdomyosarcoma at St. Jude Children’s Research Hospital, 1962-1978. Natl Cancer Inst Monogr 56:93–101, 1981.
Ghavimi F, Exelby PR, D’Angio GJ, et al.: Multidisciplinary treatment of embryonal rhabdomyosarcoma in children. Cancer 35:677–686, 1975.
Maurer HM, Gehan EA, Beltangady M, et al.: The Intergroup Rhabdomyosarcoma Study II. Cancer, in press.
Maurer H, Gehan E, Crist W, et al.: Intergroup rhabdomyosarcoma study (IRS) III: A preliminary report of overall outcome. Proc Amer Soc Clin Oncol 8:296, 1989.
Kun L, Etcubanas E, Pratt C, et al.: Treatment factors affecting local control in childhood rhabdomyosarcoma (Abstr). Proc Am Soc Clin Oncol 5:207, 1986.
Tefft M, Wharam M, Gehan E: Local and regional control by radiation in IRS II. Int J Rad Oncol Biol Phys 16(Suppl 1):159, 1988.
Crist WM, Raney RB, Ragab A, et al.: Intensive chemotherapy including cisplatin with and without etoposide for children with soft tissue sarcomas. Med Pediatr Oncol 15:51–57, 1987.
Rao BN, Etcubanas EE, Horowitz M, et al.: The results of conservative management of extremity soft tissue sarcomas in children. Proc Ann Meet Am Soc Clin Oncol 5:266, 1986.
Brizel DM, Weinstein H, Hunt M, et al.: Failure pattern and survival in childhood soft tissue sarcomas. Proc Amer Soc Therapeut Radiat Oncol 29:183, 1988.
Mandell LR, Ghavini F, Exelby P, Fuks Z: Preliminary results of alternating combination chemotherapy (CT) and hyperfractionated radiotherapy (HART) in advanced rhabdomyo-sarcoma (RMS). Int J Radiat Oncol Biol Phys 15:197–203, 1988.
Carli M, Perilongo GT, Paolucci P, et al.: Role of primary chemotherapy in childhood malignant mesenchymal tumors other than rhabdomyosarcoma. Preliminary results. Proc Am Soc Clin Oncol 5:208, 1986.
Olive D, Famant F, Rodary C, et al.: Responsiveness of nonrhabdomyosarcoma malignant mesenchymal tumors (NRMMT) to primary chemotherapy (CT). Proc XXth Meeting SIOP, Trondheim, Norway, p 118, 1988.
Rosenberg SA, Tepper J, Glatstein E, et al.: Prospective randomized evaluation of adjuvant chemotherapy in adults with soft tissue sarcomas of the extremities. Cancer 52:424–434, 1983.
Antman K, Suit H, Amato D, et al.: Preliminary results of a randomized trial of adjuvant doxorubicin for sarcomas: Lack of apparent difference between treatment groups. J Clin Oncol 2:601–608, 1984.
Suit HD, Manken HJ, Schiller AL, et al.: Results of treatment of sarcomas of soft tissue by radiation and surgery at Massachusetts General Hospital. Cancer Treat Symp 3:43–47, 1985.
Bramwell VH, Mouridsen HT, Santoro A, et al.: Cyclophosphamide versus ifosfamide: Final report of a randomized Phase II trial in adult soft tissue sarcomas. Eur J Cancer Clin Oncol 23:311, 1987.
Stuart-Harris R, Harper PG, Kaye SB, Willshaw E: High-dose ifosfamide by infusion with mesna in advanced soft tissue sarcoma. Cancer Treat Rev 10(Suppl A):163–164, 1983.
Suit HD: Patterns of failure after treatment of sarcoma of soft tissue by radical surgery or by conservative surgery and radiation. Cancer Treat Symp 2:241–246, 1983.
Potter DA, Glenn J, Kinsella T, et al.: Patterns of recurrence in patients with high-grade soft-tissue sarcomas. J Clin Oncol 3:353–366, 1985.
Collin C, Godbold J, Hajdu S, Brennan M: Localized extremity soft tissue sarcoma: An analysis of factors affecting survival. J Clin Oncol 5:601–612, 1987.
Roth JA, Putnam JB, Jr, Wesley MN, Rosenberg SA: Differing determinants of prognosis following resection of pulmonary metastasis from osteogenic and soft tissue sarcomas. Cancer 55:1361–1366, 1988.
Ueda T, Aozasa K, Tsujimoto M, et al.: Multivariate analysis for clinical prognostic factors in 163 patients with soft tissue sarcoma. Cancer 62:1444–1450, 1988.
Mandard AM, Petiot JF, Marnay J, et al.: Prognostic factors in soft tissue sarcomas: A multivariate analysis of 109 cases. Cancer 63:1437–1451, 1989.
Shiraki M, Enterline HT, Brooks JJ, et al.: Pathologic analysis of advanced adult soft tissue sarcomas, bone sarcomas and mesotheliomas. The Eastern Cooperative Oncology Group (ECOG) experience. Cancer 64:484–490, 1989.
Eilber FR, Morton DL, Eckardt J, et al.: Limb salvage for skeletal and soft tissue sarcomas: Multidisciplinary preoperative therapy. Cancer 53:2579–2584, 1984.
Lindberg RD, Martin RG, Romsdahl MM, Barkley HT, Jr: Conservative surgery and postoperative radiotherapy in 300 adults with soft tissue sarcomas. Cancer 47:2391–2397, 1981.
Slater JD, McNeese MD, Peters LJ: Radiation therapy for unresectable soft tissue sarcomas. Int J Radiat Oncol Biol Phys 12:1729–1734, 1986.
Suit HD, Maukin HJ, Wood WC, Proppe KH: Preoperative, intraoperative, and postoperative radiation in the treatment of primary soft tissue sarcoma. Cancer 55:2659–2667, 1985.
Fontanesi J, Kun L, Pao W, et al.: Brachytherapy as primary or “boost” irradiation in 18 children with solid tumors. Int J Endocurie Therapy/Hyperthermia Oncol, submitted.
Curran WJ, Jr, Littman P, Raney RB: Interstitial radiation therapy in the treatment of childhood soft-tissue sarcomas. Int J Radiat Oncol Biol Phys 14:169–174, 1988.
Knight PJ, Doornbos JF, Rosen D, et al.: The use of interstitial radiation therapy in the treatment of persistent, localized, and unresectable cancer in children. Cancer 57:951–954, 1986.
Pratt C, James DH, Holton CP, Pinkel D: Combination therapy including vincristine for malignant solid tumors in children. Cancer Chemother Rep 52:489–495, 1968.
Pinkel D: Cyclophosphamide in children with cancer. Cancer 15:42–49, 1962.
Pinkel D: Actinomycin D in childhood cancer: A preliminary report. Pediatrics 23:342–347, 1959.
Gottleib JA, Baker LH, O’Bryan RM, et al.: Adriamycin (NSC-123127) used alone and in combination for soft tissue and bony sarcomas. Cancer Chemother Rep 6(Pt 3):271–282, 1975.
Tan C, Rosen G, Ghavimi F, et al.: Adriamycin (NSC-123127) in pediatric malignancies. Cancer Chemother Rep 6(Pt 3):259–266, 1975.
Gottleib JA, Benjamin RS, Baker LM, et al.: Role of DTIC (NSC-45388) in the chemotherapy of sarcomas. Cancer Treat Rep 60:199–203, 1976.
Pratt CB, Hayes FA, Green AA, et al.: Pharmacokinetic evaluation of cisplatin in children with malignant solid tumors. A phase II study. Cancer Treat Rep 65:1021–1026, 1981.
O’Dwyer PJ, Leyland-Jones B, Alonso MT, et al.: Etoposide (VP-16,213): Current status of an active anticancer drug. N Engl J Med 312:692–700, 1985.
Magrath I, Sandlund J, Raynor A, et al.: A phase II study of ifosfamide in the treatment of recurrent sarcomas in young people. Cancer Chemother Pharmacol 18(Suppl 2):S25–S28, 1985.
Pratt CB, Douglass EC, Goren MP, et al.: Clinical studies of ifosfamide/mesna at St. Jude Children’s Research Hospital, 1983-1988. Semin Oncol 16(Suppl 3):51–55, 1989.
Grier HE, Perez-Atayde AR, Weinstein HJ: Chemotherapy for inoperable infantile fibro-sarcoma. Cancer 56:1507–1510, 1985.
Horowitz M, Balis F, Pastakia B, et al.: Integration of ifosfamide and VP-16 (IE) into the frontline therapy of pediatric sarcomas (PS). Proc Ann Meet Am Soc Clin Oncol 7:260, 1988.
Castello MA, Clerico A, Jenkner A, Dominici C: High-dose carboplatin and etoposide in children with malignant solid tumors. Proc XXth Meeting SIOP, Trondheim, Norway, p 195, 1988.
Miser JS, Kinsella TJ, Triche TJ, et al.: Ifosfamide with Mesna uroprotection and etoposide: An effective regimen in the treatment of recurrent sarcomas and other tumors of children and young adults. J Clin Oncol 5:1191–1198, 1987.
Edmonson JH, Fleming TR, Ivins JC, et al.: Randomized study of systemic chemotherapy following complete excision of non-osseous sarcoma. J Clin Oncol 2:1390–1396, 1984.
de Paula U, Suit HD, Harmon D: Adjuvant chemotherapy in clinical stage M0 sarcoma of soft tissue. Cancer 62:1907–1911, 1988.
Flamant F, Rodary C, Rey A, Praquin MT: Preliminary report on the SIOP protocol for malignant mesenchymal tumors. Proc XVIIth Meeting SIOP, Venice, Italy, pp 81–84, 1985.
Kung FH, Pratt CD, Krischer JP: Ifosfamide and VP-16 in the treatment of recurrent malignant solid tumors of childhood. Proc Ann Meet Am Soc Clin Oncol 8:301, 1989.
Stout AP: Fibrosarcoma in infants and children. Cancer 5:1028–1040, 1962.
Soule EH, Pritchard DJ: Fibrosarcoma of infants and children: A review of 110 cases. Cancer 40:1711–1721, 1977.
Ninane J, Gosseye S, Panteon E, et al.: Congenital fibrosarcoma: Preoperative chemotherapy and conservative surgery. Cancer 58:1400–1406, 1986.
Blocker S, Koenig J, Ternberg J: Congenital fibrosarcoma. J. Pediatr Surg 22:665–670, 1987.
Gansar GF, Krementz ET: Desmoid tumors: Experience with new modes of therapy. South Med J 81:794–796, 1988.
Raney RB: Synovial sarcoma. Med Pediatr Oncol 9:41–45, 1981.
Kauffman SL, Stout AP: Hemangiopericytoma in children. Cancer 13:695–710, 1960.
Shmookler BM, Enzinger FM: Juvenile liposarcoma: An analysis of 15 cases. Am J Clin Pathol 133:245–246, 1982.
Weiss SW, Enzinger FM: Malignant fibrous histiocytoma: An analysis of 200 cases. Cancer 41:2250–2266, 1978.
Raney RB, Allen A, O’Neill J, et al.: Malignant fibrous histiocytoma of soft tissue in childhood. Cancer 57:2198–2201, 1986.
Mayer CMH, Favara BE, Holton CP, Rainer G: Malignant mesenchymoma in infants. Am J Dis Child 128:847–850, 1974.
Ducatman BS, Scheithauer BW, Piepgras DG, et al.: Malignant peripheral nerve sheath tumors: A clinicopathologic study of 120 cases. Cancer 57:2006–2021, 1986.
Raney RB, Schnaufer L, Zeigler M, et al.: Treatment of children with neurogenic sarcoma. Cancer 59:1–5, 1987.
Enzinger FM, Weiss SW: Malignant tumors of uncertain histogenesis. In: Soft tissue tumors, 2nd edition. Enzinger FM, Weiss SW, (eds). St Louis: CV Mosby, pp 929–965, 1988.
Nakashima Y, Unni KK, Shives TC, et al.: Mesenchymal chondrosarcoma of bone and soft tissue: A review of 111 cases. Cancer 57:2444–2453, 1986.
Chase DR, Enzinger FM: Epithelioid sarcoma: Diagnosis, prognostic indications and treatment. Am J Surg Pathd 9:241–263, 1985.
Kawamoto EH, Weidner N, Agostini RM, Jr, Jaffe R: Malignant ectomesenchymoma of soft tissue: Report of 2 cases and review of the literature. Cancer 59:1791–1802, 1987.
Soule EH, Newton W, Moon TE, Tefft M: Extraskeletal Ewing’s sarcoma. Cancer 42:259–264, 1968.
Askin FB, Rosai J, Sibley RK, et al.: Malignant small cell tumor of the thoracopulmonary region in childhood: A distinctive clinicopathologic entity of uncertain histogenesis. Cancer 43:2438–2451, 1979.
Llombart-Bosch A, Lacombe MJ, Contesso G, Peydro-Olaya A: Small round blue cell sarcoma of bone mimicking atypical Ewing’s sarcoma with neuroectodermal features. Cancer 60:1570–1582, 1987.
Shimada H, Newton W, Soule E, et al.: Pathologic features of extraosseous Ewing’s sarcoma. Hum Pathol 19:422–453, 1988.
Cavazzana AD, Ninfo V, Montesco M, et al.: Peripheral neuroepithelioma: Morphologic and immunologic criteria for diagnosis (Abstr). Mod Pathol 1:17, 1988.
Marina NM, Etcubanas E, Parham D, et al.: Peripheral primitive neuroectodermal tumor (peripheral neuroepithelioma) in children: A review of the St. Jude experience and controversies in diagnosis and management. Cancer 64:1952–1960, 1989.
Laskin WB, Silverman TA, Enzinger FM: Postradiation soft tissue sarcomas: An analysis of 53 cases. Cancer 62:2330–2340, 1988.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1991 Springer Science+Business Media New York
About this chapter
Cite this chapter
Pratt, C.B., Kun, L.E. (1991). Soft Tissue Sarcomas of Children. In: Pinedo, H.M., Verweij, J., Suit, H.D. (eds) Soft Tissue Sarcomas: New Developments in the Multidisciplinary Approach to Treatment. Cancer Treatment and Research, vol 56. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-3896-7_11
Download citation
DOI: https://doi.org/10.1007/978-1-4615-3896-7_11
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-6738-3
Online ISBN: 978-1-4615-3896-7
eBook Packages: Springer Book Archive